The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells
Breast cancer is the most commonly diagnosed cancer in women. Resveratrol, a naturally occurring phytochemical, shows great promise in developing novel anti-cancer therapies. This study hypothesized that the mitochondria-targeted delivery of resveratrol would increase its potency and induce mitochon...
Main Authors: | Lingling Jiang, Han Yu, Chenwei Wang, Fujin He, Zhongqi Shi, Haohong Tu, Na Ning, Shaofeng Duan, Yunqi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/10/1271 |
Similar Items
-
Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells
by: Ji Hee Kang, et al.
Published: (2019-08-01) -
Self-Assembled Triphenylphosphonium-Conjugated Dicyanostilbene Nanoparticles and Their Fluorescence Probes for Reactive Oxygen Species
by: Wonjin Choi, et al.
Published: (2018-12-01) -
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
by: Ludmila A. Zinovkina, et al.
Published: (2020-03-01) -
Triphenylphosphonium-Functionalized Gold Nanorod/Zinc Oxide Core–Shell Nanocomposites for Mitochondrial-Targeted Phototherapy
by: Ara Joe, et al.
Published: (2024-02-01) -
Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function
by: Diego Méndez, et al.
Published: (2024-06-01)